Spotlight: Creusot lab receives Berrie Fellowship

New area of research
Monday, April 11, 2016 - Tuesday, May 31, 2016

 The Creusot lab’s main goal is to understand antigen-presenting cells that have immune tolerance-inducing (tolerogenic) properties, and empowering them to re-educate the self-reactive T cells that are responsible for the attack on insulin-producing cells in Type 1 diabetes. Our research encompasses basic, translational and preclinical studies, with the main projects shown on the illustration. The lab is currently supported by two R21 grants from the National Institute of Allergy and Infectious Diseases.

  • Seminar Series
  • Core Services 
  • Apply for a Pilot Grant
  • NBDC